We are live on ! Find out more
GMED icon

Globus Medical

259 hedge funds and large institutions have $2.88B invested in Globus Medical in 2019 Q2 according to their latest regulatory filings, with 34 funds opening new positions, 100 increasing their positions, 84 reducing their positions, and 41 closing their positions.

New
Increased
Maintained
Reduced
Closed

19% more repeat investments, than reductions

Existing positions increased: 100 | Existing positions reduced: 84

1.14% more ownership

Funds ownership: 87.67%88.81% (+1.1%)

4% less funds holding

Funds holding: 269259 (-10)

13% less capital invested

Capital invested by funds: $3.3B → $2.88B (-$420M)

17% less first-time investments, than exits

New positions opened: 34 | Existing positions closed: 41

40% less funds holding in top 10

Funds holding in top 10: 53 (-2)

81% less call options, than puts

Call options by funds: $3.42M | Put options by funds: $17.8M

Holders
259
Holders Change
-10
Holders Change %
-3.72%
% of All Funds
5.63%
Holding in Top 10
3
Holding in Top 10 Change
-2
Holding in Top 10 Change %
-40%
% of All Funds
0.07%
New
34
Increased
100
Reduced
84
Closed
41
Calls
$3.42M
Puts
$17.8M
Net Calls
-$14.4M
Net Calls Change
-$14.3M
Name Holding Trade Value Shares
Change
Change in
Stake
WCM
201
Weld Capital Management
New York
$226K +$232K +5,342 New
Mitsubishi UFJ Asset Management
202
Mitsubishi UFJ Asset Management
Japan
$224K +$52.2K +1,203 +29%
LTFS
203
Ladenburg Thalmann Financial Services
Florida
$215K -$26.1K -601 -11%
Zurich Cantonal Bank
204
Zurich Cantonal Bank
Switzerland
$214K +$41K +943 +23%
QCM
205
Quantinno Capital Management
New York
$211K -$90.8K -2,091 -30%
US Bancorp
206
US Bancorp
Minnesota
$203K -$110K -2,528 -34%
LIA
207
LS Investment Advisors
Michigan
$202K -$8.34K -192 -4%
QT
208
Quantbot Technologies
New York
$198K +$153K +3,527 +301%
Macquarie Group
209
Macquarie Group
Australia
$195K +$200K +4,600 New
OAM
210
Oppenheimer Asset Management
New York
$168K -$133K -3,071 -44%
AG
211
Advisor Group
Arizona
$124K -$30K -691 -19%
NIT
212
NumerixS Investment Technologies
British Columbia, Canada
$118K -$173K -3,989 -59%
QT
213
Quantamental Technologies
New York
$88K +$90.4K +2,082 New
DMK
214
David M. Knott
$80K
PHK
215
Point72 Hong Kong
Hong Kong
$72K +$74.3K +1,711 New
AssetMark Inc
216
AssetMark Inc
California
$56K
Ohio Public Employees Retirement System (OPERS)
217
Ohio Public Employees Retirement System (OPERS)
Ohio
$53K -$276K -6,346 -83%
Fidelity Investments
218
Fidelity Investments
Massachusetts
$48K -$50.2K -1,155 -50%
FPS
219
Fieldpoint Private Securities
Connecticut
$47K +$48.7K +1,122 New
HIIFS
220
Harel Insurance Investments & Financial Services
Israel
$42K
QCG
221
Quadrant Capital Group
Ohio
$38K +$18.5K +425 +89%
OC
222
Oakworth Capital
Alabama
$38K +$39.1K +900 New
FL
223
Fort LP
Maryland
$37K +$38.3K +881 New
CAW
224
Cornerstone Advisors (Washington)
Washington
$36K
ASN
225
Advisory Services Network
Georgia
$34K +$29.6K +682 +620%

GMED Hedge Fund Activity: Q2 2019 in Review

259 of the 4,604 institutional investors tracked by Wall St. Rank reported a position in Globus Medical (GMED) for Q2 2019, worth a combined $2.88B — down 13% from $3.3B a quarter earlier.

Sellers outnumbered buyers: 41 funds closed out of GMED and 34 opened new positions — a net loss of 7 holders — while 84 trimmed existing stakes and 100 added.

The largest buyer was Janus Henderson Group, adding an estimated $122M. The largest seller was Victory Capital Management, exiting entirely with an estimated $45.6M sold.

  • 259 institutional investors held Globus Medical (GMED) as of Q2 2019, down from 269 in Q1 2019.
  • Funds reported $2.88B of Globus Medical stock for Q2 2019, down 13% quarter-over-quarter.
  • 34 funds opened new Globus Medical positions in Q2 2019 and 41 closed out, a net change of -7 holders.
  • The largest Globus Medical buyer in Q2 2019 was Janus Henderson Group, an estimated $122M added.
  • The largest Globus Medical seller in Q2 2019 was Victory Capital Management, an estimated $45.6M sold.

Based on aggregated 13F filings for Q2 2019.